Preparation and in vitro characterization of curcuminoids-loaded nanostructured lipid carriers for intravenous injection

Chinese Journal of New Drugs

Volumn 22, Issue 9, 2013, Pages

  Xiao, Yan Yu ^a   Chen, Xi ^a   Zou, Lang ^b   Chen, Zhi Peng ^c   Ping, Qi Neng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Curcuminoids; Hemolysis; Intravenous injection; Nanostructured lipid carriers; Physicochemical properties

Indexed keywords

CURCUMIN; LIPID; NANOCARRIER;

ARTICLE; BRAIN; BRAIN TUMOR; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; EMULSION; ENCAPSULATION; EXPERIMENT; HEMOLYSIS; IN VITRO STUDY; MORPHOLOGY; PARTICLE SIZE; ZETA POTENTIAL;

EID: 84881297914     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 2003, 30(5): 254-257.
2. MORAGODA L, JASZEWSKI R, MAJUMDAR A P. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells[J]. Anticancer Res, 2001, 21(2A): 873-878.
3. NAGAI S, KURIMOTO M, WASHIYAMA K, et al. Inhibition of cellular proliferation and induction of apoptosis by curcumin in human malignant astrocytoma cell lines[J]. J Neurooncol, 2005, 74(2): 105-111.
4. GAO X, DEEB D, JIANG H, et al. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria[J].J Exp Ther Oncol, 2005, 5(1): 39-48.
5. BELKAID A, COPLAND I B, MASSILLON D, et al. Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin[J]. FEBS Lett, 2006, 580(15): 3746-3752.
6. KARMAKAR S, BANIK N L, PATEL S J, et al. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells[J]. Neurosci Lett, 2006, 407(1): 53-58.
7. AOKI H, TAKADA Y, KONDO S, et al. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways[J]. Mol Pharmacol, 2007, 72(1): 29-39.
8. LIU E, WU J, CAO W, et al. Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma[J]. J Neurooncol, 2007, 85(3): 263-270.
9. 2008, 29(5): 355-358.
10. LOPEZ-LAZARO M. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent[J]. Mol Nutr Food Res, 2008, 52(Suppl 1): S103-S127.
11. FANG C, SHI B, PEI Y Y, et al. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size[J]. Eur J Pharm Sci, 2006, 27(1): 27-36.
12. GULYAER A E, GELPERINA S E, SKIDAN I N, et al. Significant transport of doxorubicin into the brain with polysorbate 80 coated nanoparticles[J]. Pharm Res, 1999, 16(10): 1564-1569.
13. ALYAUTDIN R, GOTHIER D, PETROV V, et al. Analges activity of the hexapeptide dalargin adsorbed on surface of polysorbate 80-coated poly (butylcyanacrylate) nanoparticles[J]. Eur J Pharm Biopharm, 1995, 41(1): 44-48.
14. SUN W, XIE C, WANG H, et al. Special role of polysorbate 80 coating on the targeting of nanoparticles to the brain[J]. Biomaterials, 2004, 25(15): 3065-3071.
15. KREUTER J. Nanoparticulate systems for brain delivery of drugs[J]. Adv Drug Deliv Rev, 2001, 47(1): 65-81.